BP, Cardiovascular Disease, and Death in the Folic Acid for Vascular Outcome Reduction in Transplantation Trial

The optimal BP level in kidney transplant recipients remains uncertain. This post hoc analysis of the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) trial cohort assessed associations of BP with a pooled cardiovascular disease (CVD) outcome and with all-cause mortality. In 34...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Carpenter, Myra A., John, Alin, Weir, Matthew R., Smith, Stephen R., Hunsicker, Lawrence, Kasiske, Bertram L., Kusek, John W., Bostom, Andrew, Ivanova, Anastasia, Levey, Andrew S., Solomon, Scott, Pesavento, Todd, Weiner, Daniel E.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Nephrology 2014
Assuntos:
Clinical Epidemiology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4073424/
https://ncbi.nlm.nih.gov/pubmed/24627349
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2013040435
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados